Denemek ALTIN - Özgür
Romaco begins local format part production in India
Express Pharma
|December 2025
The Noack N 950E blister packaging machine with Indian-produced format parts to debut at CPHI & PMEC India 2025, followed by installation at the Romaco India Experience Centre in Hyderabad
-
At CPHI & PMEC India in Delhi, Romaco will be exhibiting the Noack N 950E blister packaging machine, equipped for the first time with format parts from India. This marks the launch of format part production in India for Romaco Noack’s blister packaging machines. The new strategic realignment will enable Romaco to dramatically shorten delivery times for format part production. After the trade fair, the N 950E will be ready for use as a test machine at the Romaco India Experience Centre.
Pharmaceutical machinery manufacturer Romaco is bolstering its presence in India and ensuring close proximity to customers by localising format part production for its Noack 900 blister packaging machine series. Users will benefit from shorter delivery times of these locally produced format parts, which will satisfy the same quality criteria as their European counterparts. Furthermore, the resulting reduction in transport mileage will have a positive impact on the carbon footprint of these machine components, which aligns perfectly with Romaco’s sustainability strategy.
Since it was founded in 2019, the Sales & Service Centre Romaco India in Mumbai has enjoyed continuous growth. The official opening of the Romaco India Experience Centre in Hyderabad was a key highlight last year. This state-of-the art customer and training centre also houses a processing laboratory, which pools Romaco’s expertise in granulating, tableting and coating pharmaceutical solids.
Bu hikaye Express Pharma dergisinin December 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Express Pharma'den DAHA FAZLA HİKAYE
Express Pharma
Future opportunities in biologics and biosimilars will demand significant investment
Semaglutide's patent expiry in India in March 2026 has become the immediate trigger for the next wave of pharmaceutical development activity, but the larger opportunity goes well beyond semaglutide itself.
1 mins
April 2026
Express Pharma
Gandhi Automations elevates loading bay efficiency with advanced dock leveler solutions
Engineered systems from Gandhi Automations Pvt Ltd enhance safety, durability and seamless material flow
2 mins
April 2026
Express Pharma
Redefining humidity control in pharma manufacturing
Bry-Air systems reflect shift towards material-based humidity control in pharma manufacturing
2 mins
April 2026
Express Pharma
2026 amendments to NDCT Rules: Foreword to India's biosimilars story or a step too short?
Kosturi Ghosh, Partner, and Ajeya B G, Sr Associate, in the Corporate practice at Trilegal, assess India's 2026 NDCT amendments as a timely push for biosimilars, but not enough on their own. The article highlights that stronger policy clarity and ecosystem support will be critical to truly unlock growth.
4 mins
April 2026
Express Pharma
Optima advances digital twins to boost efficiency in pharmaceutical turnkey machines
Virtual testing, training and simulation tools enhance performance in complex manufacturing environments
7 mins
April 2026
Express Pharma
Complete environmental monitoring solution – testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
3 mins
April 2026
Express Pharma
Flexotherm heating tapes & cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
April 2026
Express Pharma
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover other critical drug categories in phases, all segments of the pharma value chain need to tighten their systems, analyses Viveka Roychowdhury
15 mins
April 2026
Express Pharma
This is only the beginning of a much larger global patent-cliff cycle
As the patent expiry of semaglutide is almost there in India, several Indian pharma firms are preparing to introduce generic versions, highlighting the sector's agility in responding to high-value loss-of-exclusivity opportunities.
1 min
April 2026
Express Pharma
Leading people in the age of Al
As Al reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and work, finds Lakshmipriya Nair
8 mins
April 2026
Listen
Translate
Change font size

